Revolutionizing the treatment of fibrotic disease.
Blade Therapeutics Announces Initiation of Phase 1 Study of Lead Calpain Inhibitor BLD-2660 for Fibrosis July 17, 2018
Blade Therapeutics Announces Initiation of Phase 1 Study of Lead Calpain Inhibitor BLD-2660 for Fibrosis
Blade Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference March 6, 2018
Blade Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
more news »
Learn More
